title: A sensitive time-resolved immunofluorometric assay for the measurement of apolipoprotein B in cerebrospinal fluid. Application to multiple sclerosis and other neurological diseases.
abstract: Although low density lipoprotein receptors have been described on oligodendrocytes, apolipoprotein B was thought to be absent or present in only very small amounts in cerebrospinal fluid (CSF). Several immunoassays have been used for the measurement of apolipoprotein B in serum. However, the majority of methods cannot be used to measure small amounts of apolipoprotein B in CSF. In this study, we describe a highly sensitive time resolved immunofluorometric assay (TR-IFMA) using europium as label (detection limit: 0.3 microgram/l). The reliability of the TR-IFMA for the measurement of apolipoprotein B was first studied in serum. Serum and CSF apolipoprotein B concentrations were then determined in subjects free of neurological disorders and in patients with multiple sclerosis. Local intrathecal apolipoprotein B synthesis was calculated. Although the high sensitivity of the TR-IFMA allowed low amounts of apolipoprotein B in CSF to be detected (0.11 +/- 0.06; 0.12 +/- 0.06 mg/l in controls and multiple sclerosis patients, respectively), no apolipoprotein B could be detected in CSF by electroimmunodiffusion. As suggested by the blood/CSF apolipoprotein B ratio (about 6000), no apolipoprotein B synthesis was observed by both using apolipoprotein B index and formula. This indicates its probable serum origin. Moreover, there was no difference between controls and multiple sclerosis patients in CSF, serum, blood/CSF, index, and local intrathecal apoliprotein B synthesis. Finally, these results suggest that the role of apolipoprotein B in lipid transport in the central nervous system may be questionable.
authors.affiliation: Laboratoire de Biochimie, INSERM U 134, Hôpital de la Salpêtrière, Paris, France.
authors.forename: I
authors.initials: I
authors.lastname: Osman
authors.forename: O
authors.initials: O
authors.lastname: Gaillard
authors.forename: D
authors.initials: D
authors.lastname: Meillet
authors.forename: M
authors.initials: M
authors.lastname: Bordas-Fonfrède
authors.forename: A
authors.initials: A
authors.lastname: Gervais
authors.forename: E
authors.initials: E
authors.lastname: Schuller
authors.forename: J
authors.initials: J
authors.lastname: Delattre
authors.forename: A
authors.initials: A
authors.lastname: Legrand
mesh_terms: D000328:Adult; D000368:Aged; D001055:Apolipoproteins B / Q000097:blood / Q000134:cerebrospinal fluid*; D005260:Female; D015200:Fluoroimmunoassay / Q000379:methods*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000097:blood / Q000134:cerebrospinal fluid*; D009391:Nephelometry and Turbidimetry; D009422:Nervous System Diseases / Q000097:blood / Q000134:cerebrospinal fluid*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
chemical_list: D001055:Apolipoproteins B